1. Expression of GRP78 and its copartners in HEK293 and pancreatic cancer cell lines (BxPC-3/PANC-1) exposed to MRI and CT contrast agents
   Ali Ahmed Azzawri et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
2. Toxicity Mechanism of Low Doses of NaGdF4:Yb3+,Er3+ Upconverting Nanoparticles in Activated Macrophage Cell Lines
   Edyta Wysokińska et al, 2019, Biomolecules CrossRef
3. Effects of chemical forms of gadolinium on the spleen in mice after single intravenous administration
   Ryosuke Nakamura et al, 2022, Biochemistry and Biophysics Reports CrossRef
4. Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies
   Victor M. Lu et al, 2020, Scientific Reports CrossRef
5. Disruption of IGF‑1R signaling by a novel quinazoline derivative, HMJ‑30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U‑2 OS cells
   Yu-Jen Chiu et al, 2018, International Journal of Oncology CrossRef
6. Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review
   Susana Coimbra et al, 2024, International Journal of Molecular Sciences CrossRef
7. Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma
   Peijun Zhu et al, 2022, Biomolecules CrossRef
8. Toxicity Mechanism of Gadolinium Oxide Nanoparticles and Gadolinium Ions in Human Breast Cancer Cells
   Mohd Javed Akhtar et al, 2019, Current Drug Metabolism CrossRef
9. YC-1 induces G0/G1phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells
   Miau-Rong Lee et al, 2017, BioMedicine CrossRef
10. Significant contribution of autophagy in mitigating cytotoxicity of gadolinium ions
    Yasukazu Takanezawa et al, 2020, Biochemical and Biophysical Research Communications CrossRef
11. Gadolinium-based contrast agents suppress adipocyte differentiation in 3T3-L1 cells
    Yasukazu Takanezawa et al, 2023, Toxicology Letters CrossRef